Topics

Double-Action Antibiotic Advances In GSK's Pipeline

08:37 EDT 29 Oct 2019 | SCRIP

GlaxoSmithKline has initiated Phase III studies, EAGLE-1 and EAGLE-2, of potentially a new chemical class of oral antibiotic in patients...

      

Related Stories

 

Original Article: Double-Action Antibiotic Advances In GSK's Pipeline

NEXT ARTICLE

More From BioPortfolio on "Double-Action Antibiotic Advances In GSK's Pipeline"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...